Insider · CIK 0001517780

MORNEAU MICHAEL

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001517780

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-01-19	VKTXViking Therapeutics, Inc.F Tax Payment	VP, Finance and Administration	FTax Payment	−1,685 sh	$6.68	−$11.3K	116,062
2021-01-04	VKTXViking Therapeutics, Inc.A Award	VP, Finance and Administration	AAward	+14.7K sh	—	—	113,819
2021-01-04	VKTXViking Therapeutics, Inc.A Award	VP, Finance and Administration	AAward	+6,667 sh	—	—	120,486
2021-01-04	VKTXViking Therapeutics, Inc.F Tax Payment	VP, Finance and Administration	FTax Payment	−2,739 sh	$5.80	−$15.9K	117,747
2021-01-04	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, Finance and Administration	AAward	+33K sh	—	—	33,000
2020-09-15	VKTXViking Therapeutics, Inc.F Tax Payment	VP, Finance and Administration	FTax Payment	−1,557 sh	$6.25	−$9,731.25	97,873
2020-09-15	VKTXViking Therapeutics, Inc.A Award	VP, Finance and Administration	AAward	+4,500 sh	—	—	99,430
2020-03-31	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, Finance and Administration	AAward	+15K sh	—	—	15,000
2020-01-19	VKTXViking Therapeutics, Inc.F Tax Payment	VP, Finance and Administration	FTax Payment	−2,044 sh	$7.18	−$14.7K	92,840
2020-01-03	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, Finance and Administration	AAward	+40K sh	—	—	40,000
2019-10-31	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, Finance and Administration	AAward	+2,500 sh	—	—	2,500
2019-07-31	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, Finance and Administration	AAward	+7,500 sh	—	—	7,500
2019-01-19	VKTXViking Therapeutics, Inc.F Tax Payment	VP, Finance and Administration	FTax Payment	−2,044 sh	$8.78	−$17.9K	91,991
2019-01-03	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, Finance and Administration	AAward	+29K sh	—	—	29,000
2018-05-31	VKTXViking Therapeutics, Inc.S Sale	VP, Finance and Administration	SSale	−21.6K sh	$9.25	−$199K	94,035
2018-05-04	VKTXViking Therapeutics, Inc.F Tax Payment	VP, Finance and Administration	FTax Payment	−7,616 sh	$4.22	−$32.1K	94,035
2018-01-19	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, Finance and Administration	AAward	+52.5K sh	—	—	52,500
2018-01-19	VKTXViking Therapeutics, Inc.A Award	VP, Finance and Administration	AAward	+15K sh	—	—	101,651
2017-05-04	VKTXViking Therapeutics, Inc.F Tax Payment	VP, Finance and Administration	FTax Payment	−8,192 sh	$1.34	−$11K	80,604
2017-01-05	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, Finance and Administration	AAward	+17.6K sh	—	—	17,605
2017-01-05	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, Finance and Administration	AAward	+95K sh	—	—	95,000
2016-03-14	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, Finance and Administration	AAward	+19.9K sh	—	—	19,934
2016-03-04	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, Finance and Administration	AAward	+40K sh	—	—	40,000
2015-05-04	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, Finance and Administration	AAward	+25.5K sh	—	—	25,500
2015-05-04	VKTXViking Therapeutics, Inc.A Award	VP, Finance and Administration	AAward	+67K sh	—	—	67,000
2015-05-04	VKTXViking Therapeutics, Inc.F Tax Payment	VP, Finance and Administration	FTax Payment	+10.4K sh	$9.49	+$98.7K	77,404
2013-09-11	Trius Therapeutics IncD Disposition to Issuer	VP Finance & CAO	DDisposition to Issuer	−14.1K sh	—	—	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	VP Finance & CAO	DDisposition to Issuer	−80K sh	$9.50	−$760K	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	VP Finance & CAO	DDisposition to Issuer	−15K sh	$8.35	−$125K	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	VP Finance & CAO	DDisposition to Issuer	−30K sh	$7.37	−$221K	0
2013-07-11	Trius Therapeutics IncEmployee Stock Option (right to buy)M Exercise/Conversion	VP Finance & CAO	MExercise/Conversion	−20K sh	—	—	80,000
2013-07-11	Trius Therapeutics IncS Sale	VP Finance & CAO	SSale	−20K sh	$9.75	−$195K	12,545
2013-07-11	Trius Therapeutics IncM Exercise/Conversion	VP Finance & CAO	MExercise/Conversion	+20K sh	$4.00	+$80K	32,545
2013-05-14	Trius Therapeutics IncEmployee Stock Option (right to buy)M Exercise/Conversion	VP Finance & CAO	MExercise/Conversion	−20K sh	—	—	0
2013-05-14	Trius Therapeutics IncS Sale	VP Finance & CAO	SSale	−20K sh	$7.75	−$155K	10,635
2013-05-14	Trius Therapeutics IncM Exercise/Conversion	VP Finance & CAO	MExercise/Conversion	+20K sh	$4.00	+$80K	30,635
2013-03-07	Trius Therapeutics IncStock Option (right to buy)A Award	VP Finance & CAO	AAward	+30K sh	—	—	30,000
2012-02-22	Trius Therapeutics IncStock Option (right to buy)A Award	VP Finance & CAO	AAward	+15K sh	—	—	15,000

Recent filings

Accepted (ET)
Jan 194
MORNEAU MICHAEL0001209191-21-004095
SEC(opens sec.gov)
Jan 64
MORNEAU MICHAEL0001209191-21-002114
SEC(opens sec.gov)
Sep 164
MORNEAU MICHAEL0001209191-20-050734
SEC(opens sec.gov)
Apr 34
MORNEAU MICHAEL0001209191-20-023378
SEC(opens sec.gov)
Jan 214
MORNEAU MICHAEL0001209191-20-004311
SEC(opens sec.gov)
Jan 34
MORNEAU MICHAEL0001209191-20-001428
SEC(opens sec.gov)
Oct 314
MORNEAU MICHAEL0001209191-19-054654
SEC(opens sec.gov)
Aug 24
MORNEAU MICHAEL0001209191-19-044336
SEC(opens sec.gov)
Jan 224
MORNEAU MICHAEL0001209191-19-004861
SEC(opens sec.gov)
Jan 34
MORNEAU MICHAEL0001209191-19-001575
SEC(opens sec.gov)
May 314
MORNEAU MICHAEL0001209191-18-034494
SEC(opens sec.gov)
May 84
MORNEAU MICHAEL0001209191-18-028718
SEC(opens sec.gov)
Jan 234
MORNEAU MICHAEL0001209191-18-004973
SEC(opens sec.gov)
May 54
Viking Therapeutics, Inc.0001209191-17-030443
SEC(opens sec.gov)
Jan 54
Viking Therapeutics, Inc.0001209191-17-002391
SEC(opens sec.gov)

Companies

Address

C/O TRIUS THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE, SUITE 101

SAN DIEGO, CA, 92121